Lantern Pharma Inc. (LTRN)
LTRN Stock Price Chart
Explore Lantern Pharma Inc. interactive price chart. Choose custom timeframes to analyze LTRN price movements and trends.
LTRN Company Profile
Discover essential business fundamentals and corporate details for Lantern Pharma Inc. (LTRN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
11 Jun 2020
Employees
24.00
Website
https://www.lanternpharma.comCEO
Panna Sharma
Description
Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug development through the strategic application of artificial intelligence, machine learning, and comprehensive genomic data analysis. Their primary drug candidate, LP-100, is currently undergoing Phase II clinical trials, targeting metastatic, castration-resistant prostate cancer. The company is also advancing LP-300 as a potential combination therapy for non-small cell lung cancer adenocarcinoma, specifically in individuals who are non-smokers or have never smoked. Furthermore, their preclinical pipeline includes LP-184, an alkylating agent engineered to inflict DNA damage upon cancer cells that either overexpress specific biomarkers or exhibit mutations within their DNA repair pathways. Beyond these, Lantern Pharma maintains an antibody-drug conjugate (ADC) program for diverse cancer treatments. Central to their operations is the RADR artificial intelligence platform, which synergizes molecular data through advanced big data analytics and machine learning capabilities. Established in 2013, the company operates from its headquarters in Dallas, Texas.
LTRN Financial Timeline
Browse a chronological timeline of Lantern Pharma Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is -$0.38.
Earnings released on 15 May 2026
EPS came in at -$0.30 surpassing the estimated -$0.36 by +16.67%.
Earnings released on 30 Mar 2026
EPS came in at -$0.36 surpassing the estimated -$0.46 by +21.74%.
Earnings released on 12 Nov 2025
EPS came in at -$0.39 surpassing the estimated -$0.46 by +15.22%.
Earnings released on 13 Aug 2025
EPS came in at -$0.40 surpassing the estimated -$0.53 by +24.53%.
Earnings released on 15 May 2025
EPS came in at -$0.42 surpassing the estimated -$0.49 by +14.29%.
Earnings released on 27 Mar 2025
EPS came in at -$0.54 falling short of the estimated -$0.51 by -5.88%, while revenue for the quarter reached $100.65k .
Earnings released on 7 Nov 2024
EPS came in at -$0.42 surpassing the estimated -$0.56 by +25.00%.
Earnings released on 8 Aug 2024
EPS came in at -$0.46 surpassing the estimated -$0.55 by +16.36%.
Earnings released on 9 May 2024
EPS came in at -$0.51 falling short of the estimated -$0.43 by -18.60%.
Earnings released on 18 Mar 2024
EPS came in at -$0.39 surpassing the estimated -$0.40 by +2.50%, while revenue for the quarter reached $261.05k .
Earnings released on 8 Nov 2023
EPS came in at -$0.29 surpassing the estimated -$0.45 by +35.56%.
Earnings released on 9 Aug 2023
EPS came in at -$0.44 falling short of the estimated -$0.43 by -2.33%.
Earnings released on 9 May 2023
EPS came in at -$0.36 surpassing the estimated -$0.48 by +25.00%.
Earnings released on 20 Mar 2023
EPS came in at -$0.31 surpassing the estimated -$0.47 by +34.04%.
Earnings released on 7 Nov 2022
EPS came in at -$0.21 surpassing the estimated -$0.48 by +56.25%.
Earnings released on 8 Aug 2022
EPS came in at -$0.41 surpassing the estimated -$0.52 by +21.15%.
Earnings released on 3 May 2022
EPS came in at -$0.38 falling short of the estimated -$0.29 by -31.03%.
Earnings released on 10 Mar 2022
EPS came in at -$0.32 surpassing the estimated -$0.40 by +20.00%.
Earnings released on 1 Nov 2021
EPS came in at -$0.36 falling short of the estimated -$0.27 by -33.33%.
Earnings released on 29 Jul 2021
EPS came in at -$0.21 surpassing the estimated -$0.26 by +19.23%.
LTRN Stock Performance
Access detailed LTRN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
